Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 21.1M 19.49M 17.66M 33.04M 2.24B 33.59M 235M 92.85M 1.18B 88.66M 86.78M 3.7B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 37.67M 34.8M 31.54M 59M 4B 59.98M 419M 166M 2.1B 158M 155M 6.61B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 day+30.43%
1 week+30.43%
Current month+36.36%
1 month+36.36%
3 months-14.29%
6 months-28.57%
Current year-9.09%
1 week 0
Extreme 0.003
0
1 month 0
Extreme 0.0022
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
+30.43%+30.43%-64.71%+150.00% 1.14M
+2.91%-2.75%-35.16%-53.42% 1.64B
-0.53%-10.10% - - 1.38B
+6.40%+3.04%-34.16%+44.43% 1.25B
+0.88%+6.17%-36.65%+167.44% 1.2B
+2.70%-5.86%+26.09%+42.73% 921M
+10.37%-0.00%+146.14%+715.33% 804M
-1.28%-2.43%-6.35%+159.33% 688M
-0.76%-6.61%-35.13%+21.04% 572M
+1.42%-4.95%+16.77%-35.07% 475M
Average +5.25%-1.86%-2.57%+134.65% 893.06M
Weighted average by Cap. +2.61%-1.81%-2.55%+117.82%

Financials

2015 2016
Net sales 25.48M 22.75M 21.02M 19.05M 35.64M 2.42B 36.23M 253M 100M 1.27B 95.63M 93.59M 4B 32.33M 28.87M 26.67M 24.17M 45.22M 3.07B 45.97M 321M 127M 1.61B 121M 119M 5.07B
Net income 5.49M 4.91M 4.53M 4.11M 7.69M 522M 7.81M 54.55M 21.6M 273M 20.62M 20.18M 862M 2.06M 1.84M 1.7M 1.54M 2.88M 196M 2.93M 20.46M 8.1M 103M 7.74M 7.57M 323M
Net Debt 24.8M 22.15M 20.46M 18.54M 34.69M 2.35B 35.27M 246M 97.49M 1.23B 93.09M 91.11M 3.89B 18.56M 16.57M 15.31M 13.88M 25.96M 1.76B 26.39M 184M 72.95M 923M 69.65M 68.17M 2.91B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. AOXG Stock